Owens & Minor (NYSE:OMI) announced today that it closed its previously announced $1.6 billion acquisition of Apria.
The Richmond, Virginia-based company previously announced the planned acquisition of Apria, a developer of home medical equipment for respiratory therapy, sleep apnea treatment, negative pressure wound therapy, and continuous glucose monitoring, in January 2022.
According to a news release, the company funded the purchase with a combination of debt and cash on hand. Earlier this month, the company launched a private offering worth $500 million in senior notes with the intention of using the proceeds to finance the Apria acquisition.
“We are excited to finalize the acquisition and for Apria to become part of Owens & Minor,” President and CEO Edward A. Pesicka said in the release. “Apria is a perfect complement to our Byram business. This portfolio expansion strengthens Owens & Minor’s position in the fast-growing home health indu…